Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Efficacy of Dihydroartemisinin for Treating Acne Vulgaris [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluates the efficacy of dihydroartemisinin for acne vulgaris and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin (dihydroartemisinin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Acne Vulgaris | EARLY_Phase 1 | Status: RECRUITING